Allegion (NYSE:ALLE) Raised to Buy at Bank of America

Allegion (NYSE:ALLE) was upgraded by Bank of America from a “neutral” rating to a “buy” rating in a research note issued to investors on Friday, Marketbeat Ratings reports. The firm currently has a $200.00 price objective on the scientific and technical instruments company’s stock, up from their previous price objective of $164.00. Bank of America‘s price objective would suggest a potential upside of 13.63% from the stock’s current price.

Other research analysts have also recently issued research reports about the company. JPMorgan Chase & Co. boosted their price objective on Allegion from $150.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, July 24th. Weiss Ratings upgraded Allegion from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Robert W. Baird set a $170.00 target price on Allegion in a report on Friday, July 24th. Finally, Evercore reiterated an “outperform” rating and issued a $180.00 target price on shares of Allegion in a research report on Tuesday, September 22nd. Four equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $167.88.

Allegion Stock Performance

NYSE:ALLE opened at $176.01 on Friday. The firm’s fifty day simple moving average is $156.04 and its 200 day simple moving average is $146.13. The company has a current ratio of 1.93, a quick ratio of 1.23 and a debt-to-equity ratio of 0.96. Allegion has a twelve month low of $125.00 and a twelve month high of $183.11. The firm has a market capitalization of $14.97 billion, a price-to-earnings ratio of 23.10, a PEG ratio of 3.23 and a beta of 0.81.

Allegion (NYSE:ALLE) last announced its quarterly earnings results on Thursday, October 22nd. The scientific and technical instruments company reported $2.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.50 by $0.10. Allegion had a return on equity of 35.41% and a net margin of 15.36%. The firm had revenue of $1.17 billion during the quarter, compared to the consensus estimate of $1.14 billion. During the same period in the prior year, the firm earned $2.30 EPS. The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. As a group, equities research analysts expect that Allegion will post 8.94 earnings per share for the current fiscal year.

Insider Activity at Allegion

In other news, SVP Timothy Eckersley sold 6,417 shares of the company’s stock in a transaction on Monday, July 27th. The stock was sold at an average price of $157.26, for a total value of $1,009,137.42. Following the completion of the sale, the senior vice president owned 29,919 shares in the company, valued at $4,705,061.94. This represents a 17.66% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Steven Mizell acquired 170 shares of Allegion stock in a transaction dated Friday, August 28th. The shares were acquired at an average price of $158.28 per share, with a total value of $26,907.60. Following the transaction, the director owned 5,899 shares in the company, valued at approximately $933,693.72. This represents a 2.97% increase in their position. The disclosure for this purchase is available in the SEC filing. Company insiders own 0.64% of the company’s stock.

Institutional Trading of Allegion

Institutional investors and hedge funds have recently bought and sold shares of the stock. Dimensional Fund Advisors LP raised its holdings in shares of Allegion by 1.6% during the first quarter. Dimensional Fund Advisors LP now owns 853,222 shares of the scientific and technical instruments company’s stock valued at $123,952,000 after acquiring an additional 13,186 shares during the period. Hawk Ridge Capital Management LP boosted its stake in Allegion by 32.9% in the 1st quarter. Hawk Ridge Capital Management LP now owns 802,807 shares of the scientific and technical instruments company’s stock worth $116,640,000 after purchasing an additional 198,800 shares during the period. The Manufacturers Life Insurance Company boosted its stake in Allegion by 19.4% in the 1st quarter. The Manufacturers Life Insurance Company now owns 599,326 shares of the scientific and technical instruments company’s stock worth $87,076,000 after purchasing an additional 97,304 shares during the period. Boston Trust Walden Corp grew its position in Allegion by 8.1% during the 1st quarter. Boston Trust Walden Corp now owns 566,792 shares of the scientific and technical instruments company’s stock worth $82,349,000 after purchasing an additional 42,660 shares in the last quarter. Finally, Bank of America Corp DE grew its position in Allegion by 5.5% during the 1st quarter. Bank of America Corp DE now owns 542,132 shares of the scientific and technical instruments company’s stock worth $78,766,000 after purchasing an additional 28,449 shares in the last quarter. Institutional investors and hedge funds own 92.21% of the company’s stock.

Allegion News Roundup

Here are the key news stories impacting Allegion this week:

• Positive Sentiment: Quarterly results exceeded expectations: Allegion reported adjusted earnings of $2.60 per share, above the $2.50 consensus estimate, while revenue rose 9.6% year over year to $1.17 billion, surpassing forecasts of approximately $1.14 billion. Earnings also increased from $2.30 per share in the prior-year quarter. Allegion third-quarter earnings report
• Positive Sentiment: Management raised its 2026 guidance: Allegion now expects reported revenue growth of 9.5% to 10.5% and adjusted earnings of $9.05 to $9.10 per share. The higher outlook signals that management sees the recent demand and margin trends continuing through the remainder of the year. Allegion raises 2026 outlook
• Positive Sentiment: Americas operations led the improvement: Organic revenue in the Americas non-residential business grew at a low-double-digit rate in the third quarter. Robust regional growth, pricing and margin expansion were key drivers of the earnings beat and helped offset softer conditions in some international markets. Allegion long-term investor takeaways
• Neutral Sentiment: The market’s positive reaction places Allegion near its 12-month high, with the stock trading above both its 50-day and 200-day moving averages. This reflects stronger investor expectations, but may also leave less room for disappointment if growth or guidance momentum slows.
• Negative Sentiment: International weakness remains a headwind, making Allegion’s performance increasingly dependent on sustained Americas demand. Investors will also monitor whether the company can maintain margin gains and meet the newly raised guidance.

About Allegion

Allegion plc (NYSE:ALLE) is a global security products and solutions company focused on protecting people and property. Its portfolio includes mechanical and electronic locks, access control systems, door closers, exit devices, door controls, and commercial doors and frames.

The company serves commercial, institutional, industrial, and residential customers through well-known brands including Schlage, Von Duprin, LCN, Steelcraft, Briton, and aptiQ. Its offerings range from traditional hardware to connected and electronic access solutions designed for offices, schools, healthcare facilities, multifamily properties, and homes.

Allegion was established as an independent public company in 2013 following its separation from Ingersoll Rand.